Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Galantamine improves gait performance in patients with Alzheimer's disease.

× No keyword cloud information.

20 in total

1. Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls.

Authors: Manuel Montero-Odasso; Jennie Wells; Michael Borrie
Journal: J Am Geriatr Soc Date: 2009-02 Impact factor: 5.562

Review 2. The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?

Authors: Orit Segev-Jacubovski; Talia Herman; Galit Yogev-Seligmann; Anat Mirelman; Nir Giladi; Jeffrey M Hausdorff
Journal: Expert Rev Neurother Date: 2011-07 Impact factor: 4.618

3. Executive control deficits as a prodrome to falls in healthy older adults: a prospective study linking thinking, walking, and falling.

Authors: Talia Herman; Anat Mirelman; Nir Giladi; Avraham Schweiger; Jeffrey M Hausdorff
Journal: J Gerontol A Biol Sci Med Sci Date: 2010-05-19 Impact factor: 6.053

4. Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease.

Authors: Olivier Beauchet; Cyrille P Launay; Gilles Allali; François R Herrmann; Cedric Annweiler
Journal: Drugs Aging Date: 2014-05 Impact factor: 3.923

5. Medication for Alzheimer's disease and associated fall hazard: a retrospective cohort study from the Alzheimer's Disease Neuroimaging Initiative.

Authors: Noam U Epstein; Rong Guo; Martin R Farlow; Jaswinder P Singh; Morris Fisher
Journal: Drugs Aging Date: 2014-02 Impact factor: 3.923

Review 10. [Medication and falls in old age].

Authors: M K Modreker; W von Renteln-Kruse
Journal: Internist (Berl) Date: 2009-04 Impact factor: 0.743

Galantamine improves gait performance in patients with Alzheimer's disease.

1. Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls.

Review 2. The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?

3. Executive control deficits as a prodrome to falls in healthy older adults: a prospective study linking thinking, walking, and falling.

4. Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease.

5. Medication for Alzheimer's disease and associated fall hazard: a retrospective cohort study from the Alzheimer's Disease Neuroimaging Initiative.

6. Changes in gait variability with anti-dementia drugs: a systematic review and meta-analysis.

7. Recent advances in the assessment and treatment of falls in Parkinson's disease.

Review 8. Pharmacological treatment in Parkinson's disease: Effects on gait.

Review 9. Gait and cognition: a complementary approach to understanding brain function and the risk of falling.

Review 10. [Medication and falls in old age].